Neural Regeneration Research ›› 2022, Vol. 17 ›› Issue (12): 2659-2660.doi: 10.4103/1673-5374.339480

Previous Articles     Next Articles

Glial cells in the center of future ischemic stroke treatments

Ivó H. Hernández, Maria José Pérez-Álvarez*   

  1. Genomic Instability Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain (Hernández IH) 
    Departamento de Biología (Fisiología Animal) Facultad de Ciencias, Universidad Autónoma de Madrid, and Instituto de Biología Molecular-CBMSO, UAM/CSIC, Madrid, Spain (Pérez-Álvarez MJ)
  • Online:2022-12-15 Published:2022-05-05
  • Contact: Maria José Pérez-Álvarez, PhD, mj.perez@uam.es.
  • Supported by:
    This work was funded by grants from Departamento de Biología, Facultad de Ciencias-Universidad Autónoma de Madrid (BIOUAM03-2020) and Spanish Ministry of Science and Innovation (PID2020-115876GB-I00) (to MJPA). The funders had no role in decision to publish, or preparation of the manuscript.

PDF

71

Abstract: In the last century, increasing knowledge about glial cells has revealed their importance in brain physiology and disease and an exciting potential target for new therapeutic interventions (Hernández et al., 2021).